Obesity-Related Knee Osteoarthritis—Current Concepts

The knee is the joint most frequently involved in osteoarthritis and represents a significant contributor to patient morbidity and impaired functional status. Major risk factors include genetics, age, sex, mechanical load and obesity/metabolic syndrome. Recent studies highlighted the role of obesity...

Full description

Bibliographic Details
Main Authors: Russka Shumnalieva, Georgi Kotov, Simeon Monov
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/8/1650
_version_ 1797584120258232320
author Russka Shumnalieva
Georgi Kotov
Simeon Monov
author_facet Russka Shumnalieva
Georgi Kotov
Simeon Monov
author_sort Russka Shumnalieva
collection DOAJ
description The knee is the joint most frequently involved in osteoarthritis and represents a significant contributor to patient morbidity and impaired functional status. Major risk factors include genetics, age, sex, mechanical load and obesity/metabolic syndrome. Recent studies highlighted the role of obesity and metabolic syndrome in the pathogenesis of knee osteoarthritis not simply through increased mechanical loading but the systemic effects of obesity-induced inflammation. The current concept of knee osteoarthritis is that of a ‘whole joint disease’, which highlights the involvement not only of articular cartilage but also the synovium, subchondral bone, ligaments and muscles. Obesity and metabolic syndrome are associated with higher levels of pro-inflammatory cytokines, increased production of adipokines with both protective and destructive effects on articular cartilage, an up-regulation of proteolytic enzymes such as matrix metalloproteinases and aggrecanases and an increase in free fatty acids and reactive oxygen species induced by dyslipidemia. These findings underscore that the adequate management of knee osteoarthritis needs to include an optimization of body weight and a beneficial mobility regimen. The possible introduction of pharmacological therapy targeting specific molecules involved in the pathogenesis of obesity-related osteoarthritis will likely also be considered in future therapeutic strategies, including personalized treatment approaches.
first_indexed 2024-03-10T23:47:47Z
format Article
id doaj.art-a5d3f4564b2e44af8fa5ff926f1b013a
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-10T23:47:47Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-a5d3f4564b2e44af8fa5ff926f1b013a2023-11-19T01:53:34ZengMDPI AGLife2075-17292023-07-01138165010.3390/life13081650Obesity-Related Knee Osteoarthritis—Current ConceptsRusska Shumnalieva0Georgi Kotov1Simeon Monov2Clinic of Rheumatology, Department of Rheumatology, Medical University of Sofia, 1431 Sofia, BulgariaClinic of Rheumatology, Department of Rheumatology, Medical University of Sofia, 1431 Sofia, BulgariaClinic of Rheumatology, Department of Rheumatology, Medical University of Sofia, 1431 Sofia, BulgariaThe knee is the joint most frequently involved in osteoarthritis and represents a significant contributor to patient morbidity and impaired functional status. Major risk factors include genetics, age, sex, mechanical load and obesity/metabolic syndrome. Recent studies highlighted the role of obesity and metabolic syndrome in the pathogenesis of knee osteoarthritis not simply through increased mechanical loading but the systemic effects of obesity-induced inflammation. The current concept of knee osteoarthritis is that of a ‘whole joint disease’, which highlights the involvement not only of articular cartilage but also the synovium, subchondral bone, ligaments and muscles. Obesity and metabolic syndrome are associated with higher levels of pro-inflammatory cytokines, increased production of adipokines with both protective and destructive effects on articular cartilage, an up-regulation of proteolytic enzymes such as matrix metalloproteinases and aggrecanases and an increase in free fatty acids and reactive oxygen species induced by dyslipidemia. These findings underscore that the adequate management of knee osteoarthritis needs to include an optimization of body weight and a beneficial mobility regimen. The possible introduction of pharmacological therapy targeting specific molecules involved in the pathogenesis of obesity-related osteoarthritis will likely also be considered in future therapeutic strategies, including personalized treatment approaches.https://www.mdpi.com/2075-1729/13/8/1650knee osteoarthritismetabolic syndromeobesitypathogenesisadipokinesdisease-modifying treatment
spellingShingle Russka Shumnalieva
Georgi Kotov
Simeon Monov
Obesity-Related Knee Osteoarthritis—Current Concepts
Life
knee osteoarthritis
metabolic syndrome
obesity
pathogenesis
adipokines
disease-modifying treatment
title Obesity-Related Knee Osteoarthritis—Current Concepts
title_full Obesity-Related Knee Osteoarthritis—Current Concepts
title_fullStr Obesity-Related Knee Osteoarthritis—Current Concepts
title_full_unstemmed Obesity-Related Knee Osteoarthritis—Current Concepts
title_short Obesity-Related Knee Osteoarthritis—Current Concepts
title_sort obesity related knee osteoarthritis current concepts
topic knee osteoarthritis
metabolic syndrome
obesity
pathogenesis
adipokines
disease-modifying treatment
url https://www.mdpi.com/2075-1729/13/8/1650
work_keys_str_mv AT russkashumnalieva obesityrelatedkneeosteoarthritiscurrentconcepts
AT georgikotov obesityrelatedkneeosteoarthritiscurrentconcepts
AT simeonmonov obesityrelatedkneeosteoarthritiscurrentconcepts